355 related articles for article (PubMed ID: 33115755)
1. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2020 Oct; 371():m3873. PubMed ID: 33115755
[TBL] [Abstract][Full Text] [Related]
2. Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases.
Vinogradova Y; Dening T; Hippisley-Cox J; Taylor L; Moore M; Coupland C
BMJ; 2021 Sep; 374():n2182. PubMed ID: 34588168
[TBL] [Abstract][Full Text] [Related]
3. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2019 Jan; 364():k4810. PubMed ID: 30626577
[TBL] [Abstract][Full Text] [Related]
4. Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis.
Fitzpatrick D; Pirie K; Reeves G; Green J; Beral V
PLoS Med; 2023 Mar; 20(3):e1004188. PubMed ID: 36943819
[TBL] [Abstract][Full Text] [Related]
5. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.
Magnusson C; Baron JA; Correia N; Bergström R; Adami HO; Persson I
Int J Cancer; 1999 May; 81(3):339-44. PubMed ID: 10209946
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
Fournier A; Berrino F; Riboli E; Avenel V; Clavel-Chapelon F
Int J Cancer; 2005 Apr; 114(3):448-54. PubMed ID: 15551359
[TBL] [Abstract][Full Text] [Related]
7. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2015 May; 350():h2135. PubMed ID: 26013557
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Olsson HL; Ingvar C; Bladström A
Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study.
Close H; Mason JM; Wilson D; Hungin AP
BMC Gastroenterol; 2012 May; 12():56. PubMed ID: 22642788
[TBL] [Abstract][Full Text] [Related]
10. [Hormone replacement therapy in menopause and risk of breast cancer].
Clavel-Chapelon F; Hill C
Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer and hormone-replacement therapy in the Million Women Study.
Beral V;
Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
13. The risk of breast cancer linked to menopausal hormone therapy.
Sæther S; Bakken K; Lund E
Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1330-4. PubMed ID: 22717857
[TBL] [Abstract][Full Text] [Related]
14. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
Renoux C; Dell'aniello S; Garbe E; Suissa S
BMJ; 2010 Jun; 340():c2519. PubMed ID: 20525678
[TBL] [Abstract][Full Text] [Related]
15. Risk of breast cancer with HRT depends on therapy type and duration.
Saul H; Gursul D; Cassidy S; Vinogradova Y
BMJ; 2022 Mar; 376():o485. PubMed ID: 35260385
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer and hormone-replacement therapy: the Million Women Study.
Helmond FA
Lancet; 2003 Oct; 362(9392):1330; author reply 1330-1. PubMed ID: 14575988
[No Abstract] [Full Text] [Related]
17. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
18. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
Beral V; Bull D; Reeves G;
Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer and hormone-replacement therapy: the Million Women Study.
Bundred NJ; Morris J
Lancet; 2003 Oct; 362(9392):1329; author reply 1330-1. PubMed ID: 14575987
[No Abstract] [Full Text] [Related]
20. Cancer issues.
Marsden J; Sturdee D
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]